Skip to main content

Cannabis Does Not Impact Nonmedical Opioid Use in Opioid Use Disorder

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- For patients receiving pharmacotherapies for opioid use disorder (OUD), cannabis use is not associated with nonmedical opioid use, according to a systematic review and meta-analysis published online Jan. 16 in the American Journal of Drug and Alcohol Abuse.

Gabriel P.A. Costa, from the University of Ribeirão Preto in Brazil, and colleagues examined the impact of cannabis use on the risk for nonmedical opioid use among individuals receiving pharmacotherapies for OUD. Ten studies, with 8,367 participants and an average follow-up time of 9.7 months, were included in the final meta-analysis.

The pharmacotherapies involved were methadone, buprenorphine, and naltrexone (76.3, 21.3, and 2.4 percent, respectively). The researchers found that based on pooled odds ratios, cannabis use did not significantly influence nonmedical opioid use (odds ratio, 1.00; 95 percent confidence interval, 0.97 to 1.04; P = 0.98). Evidence of moderate heterogeneity and publication bias was observed.

"These findings neither confirm concerns about cannabis increasing nonmedical opioid use in individuals being treated for opioid use disorder, nor do they endorse its efficacy in reducing nonmedical opioid use," Costa said in a statement.

One author disclosed ties to Jazz Pharmaceuticals and Boehringer Ingelheim.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Small Number of Procedures Account for Large Number of Opioid Prescriptions

FRIDAY, June 28, 2024 -- A small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions...

Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them

THURSDAY, June 27, 2024 -- Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the...

Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures

WEDNESDAY, June 26, 2024 -- Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.